Skip to main content
CRIS
NASDAQ Life Sciences

Curis Inc. Implements 1-for-20 Reverse Stock Split to Maintain Nasdaq Listing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.44
Mkt Cap
$16.453M
52W Low
$0.181
52W High
$2.482
52W Position info
143% above low
Off High info
82% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

CRIS has more than doubled off its 52-week low of $0.181.

Summary

Curis Inc. has officially implemented a 1-for-20 reverse stock split, effective today, with split-adjusted trading beginning July 6, 2026, a critical step to regain Nasdaq compliance.


Key Events · Corporate Governance and Compliance · CRIS

  • Reverse Stock Split Implemented

    Curis Inc. filed a certificate of amendment to its Restated Certificate of Incorporation, officially effecting a 1-for-20 reverse stock split as of July 2, 2026. Trading on a split-adjusted basis will commence on July 6, 2026.

  • Nasdaq Compliance Measure

    This reverse stock split is a direct response to the company's delisting determination letter from Nasdaq, aiming to increase the per-share price to meet listing requirements.

  • No Change to Authorized Shares or Par Value

    The reverse stock split will not alter the par value of the common stock or the total number of authorized shares of common stock. All outstanding warrants, restricted stock units, and stock options will be adjusted accordingly.


Analysis · CRIS · Life Sciences

Curis Inc. has officially executed a 1-for-20 reverse stock split by filing the necessary certificate of amendment. This action is a critical step for the company to regain compliance with Nasdaq's minimum bid price requirement, following a delisting notice received in May. While a reverse split does not change the company's fundamental value, it is a necessary measure to avoid delisting and maintain access to public capital markets, especially given the company's previously disclosed 'going concern' doubt and lack of revenue.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CRIS was trading at $0.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.5M. The 52-week trading range was $0.18 to $2.48. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CRIS - Latest Insights

CRIS
Nov 13, 2026, 4:19 PM EST
Filing Type: S-3
Importance Score:
7
Price at Filing: $0.445
Real-time Price: $0.4251 info
Change: -$0.0199 (-4%) info
Market Cap: $2.972M info
CRIS
Nov 13, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.445
Real-time Price: $0.4251 info
Change: -$0.0199 (-4%) info
Market Cap: $2.972M info
CRIS
Nov 12, 2026, 4:01 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.57165
Real-time Price: $0.4251 info
Change: -$0.14655 (-26%) info
Market Cap: $2.972M info
CRIS
Nov 06, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.8481
Real-time Price: $0.4251 info
Change: -$0.423 (-50%) info
Market Cap: $2.972M info
CRIS
Oct 19, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3816
Real-time Price: $0.4251 info
Change: +$0.0435 (+11%) info
Market Cap: $2.972M info